Breast augmentation with breast implants

Breast augmentation with implants in Yerevan, Armenia (augmentation mammoplasty) is a surgical procedure to increase breast size. It has been performed regularly since the 1960s. This involves placing implants either under the breast tissue or beneath the chest muscle. Modern practice features a wide variety of implants and greater patient awareness about the procedure.

Implants may contain silicone cohesive gel (cohesiveness refers to the level of crosslinking of silicone polymers; the higher the crosslinking, the denser and more stable the gel).

• First-generation implants (1960s) were teardrop-shaped with medium-viscosity gel.
• Second-generation (1970s) were round with more fluid, lower-viscosity gel, yielding a more natural feel.
• Third-generation (1980s) returned to higher-viscosity gel and thicker shells to reduce leakage risk.
• Fifth- and sixth-generation implants were introduced after the FDA’s 1992 moratorium, meeting stricter criteria for gel cohesiveness and shell thickness; they remain in use today.

Higher cohesiveness doesn’t always mean better quality—it often feels less natural yet better supports upper-pole projection. Implant “profile” describes its silhouette: higher profile implants have narrower bases, and vice versa.

For many women, breast augmentation in Yerevan, Armenia, restores confidence or reverses changes from pregnancy or cancer. It may also address concerns such as small size or asymmetry, and restore volume after breastfeeding.

Risks

• Capsular contracture: scar tissue causing implant distortion.
• Soreness
• Infection
• Changes in sensitivity
• Implant rupture or leakage
• Silicone Implant Illness (SII/SIS): a rare autoimmune-like reaction involving muscle/joint pain, fatigue, sleep and cognitive disturbances.
• In capsular contracture cases, 98% require bilateral implant removal via capsulectomy (80%) and implant replacement; 7% do not undergo capsulectomy.
• The FDA acknowledges a very low but increased risk of breast implant–associated anaplastic large cell lymphoma (BIA‑ALCL). It appears linked to bacterial contamination (e.g., Ralstonia pickettii), with risk increasing with implant texturing. However, smooth implants may also carry some risk. Cancer risk is estimated at 1 : 1,000, occurring approximately 7.5 years post-implantation. Treatment requires implant and capsule removal. Most cases are not aggressive and may resolve without systemic malignancy.

Preparation

1. Consultation with a plastic surgeon to determine desired size, feel, and appearance—options include smooth vs textured, saline vs silicone, and round vs teardrop shapes.
2. Research implant brands and retain documentation.
3. One implant size increase roughly equals +130–150 mL.
4. Preoperative photographs are taken.
5. Surgeon shares before-and-after cases.
6. Implant size is chosen based on breast anatomy and surgeon experience—patient wishes are important but must be realistic.

Patients should know:

• Surgery won’t prevent future sagging—a mastopexy may be needed later.
• Implants have a lifespan of about 10 years; aging, weight changes, or rupture may require further surgery.
• Implants may interfere with breastfeeding—some women can nurse successfully, others cannot.
• Mammography becomes more complex; MRI or ultrasound may be required after routine imaging.
• Implants are typically not covered by insurance, except in reconstructive cases.
• Corrective surgery may be needed after implant removal to restore breast appearance.
• The FDA recommends MRI screening starting 3 years after surgery, though some studies suggest routine screening isn’t justified without symptoms.
• A baseline mammogram before surgery may be advised.
• Avoid aspirin, NSAIDs, and supplements preoperatively.
• Smoking cessation is required before and after surgery.

Procedure Details

Incision sites:

• Inframammary fold (underneath the breast)
• Transaxillary (underarm)
• Periareolar (around the nipple)

After incision, a pocket is created subglandularly or submuscularly, or in a dual-plane (partially under the muscle). Approximately 24% of procedures use the dual-plane technique.

Infection-reduction protocol (14 points):

• IV antibiotic prophylaxis at induction
• Avoid periareolar/transaxillary approach to reduce infection and contracture
• Nipple isolation before implant insertion
• Gentle tissue handling to preserve blood supply
• Meticulous hemostasis
• Avoid dissection through breast parenchyma
• Two-layer pocket creation
• Antibiotic irrigation (betadine + triple-antibiotic solution)
• Sterile skin prep
• Minimize implant exposure before insertion
• Change gloves and instruments before implant placement
• No surgical drains
• Multilayered wound closure
• Postoperative oral antibiotics

Implant types:

• Silicone-filled for natural consistency
• Saline implants placed empty and filled after insertion

Postoperative care:

• Expect swelling, soreness, and potential hematoma for weeks; scars fade over time
• A supportive compression bra or sports bra is essential
• Return to work in a few weeks if not physically strenuous
• Avoid strenuous activity for at least 2 weeks
• Monitor for signs of infection (fever, warmth, redness) and seek immediate care if symptoms or shortness of breath occur

Outcomes

Breast augmentation in Yerevan, Armenia can significantly reshape your body and improve self-esteem. Realistic expectations are crucial—additional procedures may be needed for symmetry or lift if goals are unmet.